Explore the research

The discovery of MFSD2A and LPC-mediated transport of EPA and DHA is a major scientific breakthrough with widespread implications and exciting potential clinical application areas. LYSOVETA™ by Aker BioMarine is the first LPC-EPA/DHA composition offered at scale, and for free, to the research community. We invite you to explore the original published research and to contact us for future collaboration opportunities.

Review Articles/Reading Lists (Curated by AKBM)

Scroll through this area to find some curated collections of articles.
Go to field
Go to field
Go to field
Go to field
Go to field